about
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblastsCough in idiopathic pulmonary fibrosisMucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisAmbulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trialAntacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings.Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaA polymorphism in the CTGF promoter region associated with systemic sclerosis.Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisMicroarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis.Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes.Molecular biomarkers in interstitial lung diseases.Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies.Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: insight into the functional role of mutant fibrillin-1.Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.Cough in interstitial lung disease.Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.Rituximab in severe, treatment-refractory interstitial lung disease.Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.Differences in parental- and self-report of asthma, rhinitis and eczema among Italian adolescents. SIDRIA collaborative group. Studi Italiani sui Disordini Respiratori dell' Infanzia e l'Ambiente.Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration.Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK.Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k).Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts.Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment.Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma.The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status.Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema.Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization.
P50
Q24804612-F37ED57D-CAC8-42C4-8A05-AC02DD3A896BQ28072122-40A26ED3-7810-43FD-B762-68D1124D3AE2Q28283421-A4D4B1AD-B3D9-4E46-B692-CEAAE6ADDA9EQ30847316-CE78D8B7-7C08-4E4B-A9CB-D8DCCC2ADFC3Q33749957-537C2A37-4B5A-4FB9-9F1C-F23262CA6BE6Q33802001-4CD90AE5-8A72-4815-9AB6-467DE6B1FC1AQ34019921-C118CC15-E7FD-468B-80C8-ADD1BC1306BBQ34480466-703D7E43-6F00-4591-AA27-7C8C9DC6B4FCQ34691070-C4151204-FFB7-4AF6-A4DE-2E6193EF604BQ35554387-75042212-B038-4A5B-9C69-377EBE25A956Q36264068-F4DC5F60-7812-47DC-92F9-B50E1D672DE7Q36661876-98E20270-E615-4127-87AE-D4AB5955C48FQ37112937-A022AE4B-5BD5-4839-BE94-C12817B9B332Q37345980-7DB24FC2-DEC3-4ED5-9C8F-9EB0DF6B1913Q37845609-71BAE261-A286-4B93-8A9C-543AAFDBDAD5Q37996321-7FA13965-5121-4B86-BBCB-533F48D068EAQ38220769-95401C03-36BB-431F-86C0-7F043810D193Q38262163-036A12F9-066E-44C9-8495-AB9513862A15Q38315686-4A39FCD2-439F-4E15-9040-9692A3C4BA50Q38509915-A53F26A1-C1DA-474F-9A39-540AE258948DQ38627363-D16C1A83-E579-4216-8458-6D3FAD8FDE61Q39022184-2DDE9D1D-1644-4D0E-95E9-955E19F2F22EQ39205579-15E8E9F9-568B-4FDC-A9B0-7FB547649CFFQ39305650-3F891CBE-147D-457B-AE87-C998A90A8D8BQ40234409-29B51ECB-4268-4DFF-BE1D-0382ECA1C1BFQ40630826-61DCA06C-2DA5-4C90-815D-B4C75E230C97Q40726161-3EFEB571-89FB-440F-99CD-234C5E1CCDF5Q40902696-546234FA-F1AA-4B5B-AB76-8049356E6C47Q42090906-DA8FC239-B3D9-4EC3-8306-67819D3BC13CQ42459183-2124C155-3B55-46F9-8DC7-D6E1841344C8Q42474271-572009A8-EAAC-4F0D-B2F3-E4B2E92E212AQ42517176-A66227B3-6305-4807-A38C-B16F2C89EBD6Q43998704-DDCF6F35-929B-43C9-835A-059B20FB4AFDQ44748993-310F9CB6-6317-4B6B-8FF0-7AF072FEB6F3Q45152674-9E3A48C7-E5CB-4A6A-A990-E76EDBDAA421Q45811426-74C9963E-A345-40A0-BBB2-0B83C55601C4Q46873529-BC324D5B-5AB6-4669-9316-A6FDEEBC3E50Q47213836-2C122385-35E6-4055-B59B-2E59C31ADB6EQ47252832-DE1B0071-41A7-4A7A-A1B3-B31D81DEC137Q47658588-0A2BF7DF-882E-49C9-ABB2-F8D90FB91E0F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elisabetta Renzoni
@ast
Elisabetta Renzoni
@en
Elisabetta Renzoni
@es
Elisabetta Renzoni
@nl
Elisabetta Renzoni
@sl
type
label
Elisabetta Renzoni
@ast
Elisabetta Renzoni
@en
Elisabetta Renzoni
@es
Elisabetta Renzoni
@nl
Elisabetta Renzoni
@sl
prefLabel
Elisabetta Renzoni
@ast
Elisabetta Renzoni
@en
Elisabetta Renzoni
@es
Elisabetta Renzoni
@nl
Elisabetta Renzoni
@sl
P106
P1153
6602708198
P31
P496
0000-0002-1118-797X